Invitrogen IP Suit Against Harvard Dismissed; Seeks to Deny Genetic Applications Damages | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
The US District Court for the Southern District of California last week dismissed Invitrogen’s patent suit against the President and Fellows of Harvard College at the request of both parties to the case.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.